Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, Czech Republic nám. Sítná 3105, CZ-272 01 Kladno, Czech Republic.
Int J Med Inform. 2019 Mar;123:49-53. doi: 10.1016/j.ijmedinf.2019.01.003. Epub 2019 Jan 2.
Outpatient Electronic Prescription Systems (OEPSs) are widely used in some European states, such as Denmark, Sweden and the Netherlands. The Czech OEPS (known as eRecept) was introduced in 2011, but with limited functions and voluntary usage it was not much accepted until 2018, when its usage was made compulsory not only for pharmacies, but for physicians as well.
Using data from the Czech State Institute for Drug Control (Státní ústav pro kontrolu léčiv or SÚKL in Czech) and from other sources, the system was described and data about its performance since 2013 have been obtained.
The usage of the system was very low between 2013 and 2016, whilst moderate growth was seen in 2017. By 2018, the system has been widely adopted, although some twenty per cent of Czech physicians still do not use the system at all.
A sudden rise in usage can be explained as the result of making the system compulsory starting in January 2018. Still, new features of the system are eagerly awaited and should be introduced to expand its benefits.
The Czech Republic has joined the EU countries widely using the OEPS.
门诊电子处方系统（OEPS）在一些欧洲国家（如丹麦、瑞典和荷兰）得到广泛应用。捷克的 OEPS（称为 eRecept）于 2011 年推出，但由于功能有限且为自愿使用，直到 2018 年才被广泛接受，当时不仅对药店，而且对医生都强制使用该系统。
利用捷克国家药物管制研究所（捷克语：Státní ústav pro kontrolu léčiv 或 SÚKL）和其他来源的数据，对该系统进行了描述，并获得了自 2013 年以来其使用情况的数据。
该系统在 2013 年至 2016 年间的使用率非常低，而 2017 年则出现了适度增长。到 2018 年，该系统已被广泛采用，尽管仍有 20%的捷克医生完全不使用该系统。
使用率的突然上升可以解释为从 2018 年 1 月开始强制使用该系统的结果。尽管如此，人们仍热切期待系统的新功能并引入以扩大其效益。
捷克共和国已加入广泛使用 OEPS 的欧盟国家之列。
